Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Class A Common Stock, $0.0001 par value per share
Symbol
RANI on Nasdaq
Shares outstanding
99,823,000
Price per share
$1.35
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
4,033,213
Total reported value
$2,015,817
% of total 13F portfolios
0%
Share change
-2,425,419
Value change
-$1,258,446
Number of holders
36
Price from insider filings
$1.35
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
InCube Labs, L.L.C. 22% $13,541,357 27,093,552 MIR A IMRAN 23 Oct 2025
Samsara BioCapital, L.P. 9.9% $4,939,262 9,882,477 Srinivas Akkaraju 23 Oct 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $4,939,262 9,882,477 RA Capital Management, L.P. 23 Oct 2025
Invus Global Management, LLC 10% $4,910,990 9,825,911 Raymond Debbane 16 Oct 2025
ARMISTICE CAPITAL, LLC 9.9% $3,443,000 6,260,000 Armistice Capital, LLC 30 Jun 2025
South Cone Investments Limited Partnership 4.9% $1,189,121 2,379,194 South Cone Investments Limited Partnership 20 Oct 2025
Orca Capital AG 4.3% -56% $907,979 -$1,181,941 1,891,623 -57% Orca Capital AG 22 Jul 2025

As of 30 Sep 2025, 36 institutional investors reported holding 4,033,213 shares of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI). This represents 4% of the company’s total 99,823,000 outstanding shares.

Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 245,284 $331,134 +$1,696 $1.35 4
2025 Q3 4,033,213 $2,015,817 -$1,258,446 $0.50 36
2025 Q2 6,458,632 $3,319,783 +$1,060,109 $0.51 38
2025 Q1 3,609,389 $4,577,211 -$332,794 $1.26 38
2024 Q4 3,818,467 $5,231,540 -$4,952,104 $1.37 41
2024 Q3 5,911,071 $12,767,865 +$5,999,502 $2.16 31
2024 Q2 2,893,303 $10,992,230 -$783,115 $3.80 32
2024 Q1 3,453,784 $10,741,251 +$518,051 $3.11 36
2023 Q4 338,679 $1,124,414 $3.32 1
2023 Q3 3,207,291 $6,961,738 -$172,517 $2.18 32
2023 Q2 3,227,211 $13,256,498 +$994,178 $4.12 33
2023 Q1 2,999,021 $15,474,095 +$204,505 $5.16 34
2022 Q4 2,885,107 $17,023,416 -$1,474,074 $5.90 31
2022 Q3 3,169,785 $30,361,447 +$3,575,258 $9.58 29
2022 Q2 2,818,733 $29,031,000 +$2,777,240 $10.33 24
2022 Q1 2,493,930 $33,666,000 +$16,743,364 $13.50 21
2021 Q4 1,240,919 $20,288,000 +$544,186 $16.35 21
2021 Q3 1,097,738 $19,563,000 +$19,563,012 $17.82 15